A University of Pennsylvania biotech spinout recently launched its first clinical trial of an experimental cancer treatment for hard-to-treat solid tumors. Its approach builds upon groundbreaking work ...

Clinical trials are the engine of medical progress in which hypotheses are turned into evidence that shapes guidelines and ...

For people with very serious illnesses, a clinical trial may offer the best hope for extending their life or improving their ...

A clinical trial is a research study involving a select group of people — either healthy individuals or patients dealing with a disease — who have volunteered to try a new intervention under close ...

An increasing imbalance between federally and industry-backed trials "raises concerns that research questions lacking ...

Biomarker-driven clinical trials are becoming more complex as precision medicine expands across therapeutic areas.

US policymakers have proposed reforms in an attempt to replicate Australia’s success in facilitating speedy Phase 1 clinical ...

A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they ...

At a time when biopharma R&D productivity is declining and the cost of bringing a single drug to market exceeds $2.6 billion, two companies are converging capabilities to change how clinical trials ...

Its lead program, MP101, is being evaluated in Korea's first MFDS-approved first-in-human clinical trial of a ...